MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: MorphoSys AG
16.04.2024 / 16:01 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings 1. Details of issuer | Name: | MorphoSys AG | | Street: | Semmelweisstr. 7 | | Postal code: | 82152 | | City: | Planegg
Germany | | Legal Entity Identifier (LEI): | 529900493806K77LRE72 |
2. Reason for notification | X | Acquisition/disposal of shares with voting rights | | | Acquisition/disposal of instruments | | | Change of breakdown of voting rights | | | Other reason:
|
3. Details of person subject to the notification obligation Legal entity: Novartis AG
City of registered office, country: Basel, Switzerland |
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached: 6. Total positions | | % of voting rights attached to shares
(total of 7.a.) | % of voting rights through instruments
(total of 7.b.1 + 7.b.2) | Total of both in %
(7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG | | New | 5.36 % | 0.00 % | 5.36 % | 37716423 | | Previous notification | n/a % | n/a % | n/a % | / |
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) | ISIN | Absolute | In % | | | Direct
(Sec. 33 WpHG) | Indirect
(Sec. 34 WpHG) | Direct
(Sec. 33 WpHG) | Indirect
(Sec. 34 WpHG) | | DE0006632003 | 0 | 2023370 | 0.00 % | 5.36 % | | Total | 2023370 | 5.36 % |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % | | | | 0 | 0.00 % | | | | Total | 0 | 0.00 % |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % | | | | | 0 | 0.00 % | | | | | Total | 0 | 0.00 % |
8. Information in relation to the person subject to the notification obligation| | Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). | | X | Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) | | Novartis AG | % | % | % | | Novartis Pharma AG | % | % | % | | Novartis BidCo AG | 5.36 % | % | 5.36 % |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: | Proportion of voting rights | Proportion of instruments | Total of both | | % | % | % |
10. Other explanatory remarks: Date
16.04.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: | English |
| Company: | MorphoSys AG |
| Semmelweisstr. 7 |
| 82152 Planegg |
| Germany |
| Internet: | www.morphosys.com |
| |
| End of News | EQS News Service |
1881523 16.04.2024 CET/CEST
